Global X Fds genomic biotech shares owned by Capital Analysts
Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Capital Analysts
from 13F filings
Historical chart of Capital Analysts investment in Global X Fds genomic biotech
Tip: Access up to 7 years of quarterly data
All positions including Global X Fds genomic biotech held by Capital Analysts consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Global X Fds genomic biotech by Capital Analysts
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $217k | 19k | 11.58 |
| 2023-09-30 | $175k | 17k | 10.18 |
| 2023-06-30 | $195k | 16k | 12.13 |
| 2023-03-31 | $185k | 15k | 12.33 |
| 2022-12-31 | $217k | 17k | 12.66 |
| 2022-09-30 | $152k | 12k | 12.58 |
| 2022-06-30 | $115k | 9.4k | 12.21 |
| 2022-03-31 | $162k | 11k | 15.05 |